Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 14;103(24):e38426.
doi: 10.1097/MD.0000000000038426.

Elucidating causal relationships of diet-derived circulating antioxidants and the risk of non-scarring alopecia: A Mendelian randomization study

Affiliations

Elucidating causal relationships of diet-derived circulating antioxidants and the risk of non-scarring alopecia: A Mendelian randomization study

Yuchen Ba et al. Medicine (Baltimore). .

Abstract

Previous observational studies revealed controversy about the effect of circulating antioxidants on risk of alopecia. In the present study, we investigated the causal relationships between diet-derived circulating antioxidants and 2 non-scarring alopecia using Mendelian randomization (MR). Instrumental variables for antioxidants (lycopene, retinol, ascorbate, β-carotene, α-tocopherol, and γ-tocopherol) were selected from published studies. Data for alopecia areata (AA) and androgenetic alopecia (AGA) was obtained from the FinnGen study project (R9 released in 2023), including 195 cases and 201,019 controls for AGA and 682 cases and 361,140 controls for AA. We used the inverse variance weighted method as the primary MR method. Three additional methods were used as sensitivity analysis to validate the robustness of the results. We found a causal relationship between absolute β-carotene levels and AGA risk (P = .039), but not with AA (P = .283). The results of Wald ratio showed a protective effect of absolute β-carotene levels against AGA, with per 0.1 ln-transformed β-carotene being associated with a 76% lower risk of AGA (OR: 0.24, 95% CI: 0.06-0.93). Based on the fixed effects inverse variance weighting results, we found that α-tocopherol was protective against both AGA (P = .026) and AA (P = .018). For each unit increase in α-tocopherol, the effects of change in AGA and AA were 0.02 (95% CI: 0.00-0.61) and 0.10 (95% CI: 0.01-0.67), respectively. The results did not reveal any other causal relationships. Our study identified 3 causal associations of antioxidants with the risk of non-scarring alopecia. These results provide new insights into the prevention of non-scarring alopecia through diet.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
Schematic overview of the MR study design. (A) The 3 main assumptions of MR analysis. (B) Schematic overview and framework of the present MR study design. MR = Mendelian randomization.
Figure 2.
Figure 2.
The primary MR analyses results of the causal effects of absolute circulating antioxidant levels on AGA and AA. Significant and suggestive results highlighted in bold. “-” represents not applicable. AA = alopecia areata, AGA = androgenetic alopecia, MR = Mendelian randomization.
Figure 3.
Figure 3.
The leave-one-out plots and funnel plots for significant results. (A) Leave-one-out plot for α-tocopherol on AA. (B) Leave-one-out plot for α-tocopherol on AGA. (C) Funnel plot for α-tocopherol on AA. (D) Funnel plot for α-tocopherol on AGA. AA = alopecia areata, AGA = androgenetic alopecia.
Figure 4.
Figure 4.
The primary MR analyses results of the causal effects of circulating antioxidant metabolites on AGA and AA. Significant and suggestive results highlighted in bold. “-” represents not applicable. AA = alopecia areata, AGA = androgenetic alopecia, MR = Mendelian randomization.

Similar articles

Cited by

References

    1. Kelly Y, Blanco A, Tosti A. Androgenetic alopecia: an update of treatment options. Drugs. 2016;76:1349–64. - PubMed
    1. Nestor MS, Ablon G, Gade A, et al. . Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021;20:3759–81. - PMC - PubMed
    1. Starace M, Orlando G, Alessandrini A, et al. . female androgenetic alopecia: an update on diagnosis and management. Am J Clin Dermatol. 2020;21:69–84. - PubMed
    1. Kitagawa T, Matsuda K, Inui S, et al. . Keratinocyte growth inhibition through the modification of Wnt signaling by androgen in balding dermal papilla cells. J Clin Endocrinol Metab. 2009;94:1288–94. - PMC - PubMed
    1. Zhou C, Li X, Wang C, et al. . Alopecia areata: an update on etiopathogenesis, diagnosis, and management. Clin Rev Allergy Immunol. 2021;61:403–23. - PubMed